Core Laboratories NV (CLB)
Official siteENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE
Market Cap: $387.21M
Last updated: Nov 17, 2026 at 4:15 PM ET
Core Laboratories NV (CLB) Stock Chart
Core Laboratories NV (CLB) has a latest price of $8.38 on Nov 17, 2026. Its price fell 45.5% over the past 12 months. The month-end price fell 89.0% over the 10 years through Oct 2026, a compound annual decline of 19.8%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $126.21 in Jun 2018 and its lowest $9.70 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CLB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CLB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 33.6%, and over 6 months it fell 38.8%. The month-end price fell 50.3% over the 3 years through Oct 2026, a compound annual decline of 20.8%.
| Period | Change |
|---|---|
| 1 month | -17.3% |
| 3 months | -33.6% |
| 6 months | -38.8% |
| 12 months | -45.5% |
| 12 months, with dividends | -45.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -50.3% | -20.8% |
| 5 years | -59.1% | -16.4% |
| 10 years | -89.0% | -19.8% |
Price by Year
Its best calendar year was 2024, when the price fell 2.0%, and its weakest was 2018, when it fell 45.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $10.64 | -33.6% |
| 2025 | $16.03 | -7.4% |
| 2024 | $17.31 | -2.0% |
| 2023 | $17.66 | -12.9% |
| 2022 | $20.27 | -9.1% |
| 2021 | $22.31 | -15.8% |
| 2020 | $26.51 | -29.6% |
| 2019 | $37.67 | -36.9% |
| 2018 | $59.66 | -45.5% |
| 2017 | $109.55 | -8.7% |
Trading Range
The price is 17.8% below its 50-day average of $10.20 and 36.6% below its 200-day average of $13.23.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.38 | |
| 50-day average | $10.20 | -17.8% |
| 200-day average | $13.23 | -36.6% |
Price Risk
Over 3 years, its largest fall from a peak was 65.7%.
| Measure | Value |
|---|---|
| 1-year beta | 0.88 |
| Largest fall, 1 year | -57.3% |
| Largest fall, 3 years | -65.7% |
Valuation
Core Laboratories NV traded at 21.1x earnings at the end of 2025, against a 5-year median of 23.2x and a 10-year median of 29.4x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CLB
What is CLB's 1-year price change?
Core Laboratories NV's price fell 45.5% over the past 12 months. With dividends included, the 12-month total return was -45.2%.
What is CLB's 5-year price change?
Core Laboratories NV's month-end price fell 59.1% over the 5 years through Oct 2026, a compound annual decline of 16.4%. These figures leave out dividends.
What is CLB's beta?
Core Laboratories NV's 1-year beta against the S&P 500 is 0.88, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 57.3%.
Is the CLB chart free?
Yes. Advanced Charting for CLB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CLB pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors